These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9574618)

  • 1. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
    Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
    AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
    Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
    Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
    Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
    Kadowaki T; Yano S; Araki K; Tokushima T; Morioka N
    Thorax; 2011 Apr; 66(4):361-2. PubMed ID: 21075777
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
    Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
    Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
    Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
    Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
    Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
    Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better discrimination of the nature of the synchronous pulmonary nodules with different morpho-metabolic characteristics by
    Garcia JR; Alvarez-Moro FJ; Soler M; Mourelo S; Bassa P; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):110-111. PubMed ID: 31918977
    [No Abstract]   [Full Text] [Related]  

  • 13. CT features of peripheral pulmonary carcinoid tumors.
    Meisinger QC; Klein JS; Butnor KJ; Gentchos G; Leavitt BJ
    AJR Am J Roentgenol; 2011 Nov; 197(5):1073-80. PubMed ID: 22021498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
    Shin V; Bhargava P; Brown J; Ames ED; Kang P
    Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
    Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
    Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET imaging in patients with pulmonary carcinoid tumor.
    Moore W; Freiberg E; Bishawi M; Halbreiner MS; Matthews R; Baram D; Bilfinger TV
    Clin Nucl Med; 2013 Jul; 38(7):501-5. PubMed ID: 23486331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
    Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
    J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.